JADE201 builds on clinical proof-of-concept for BAFF-R targeting, adding half-life extension technology to provide extended ...

From bispecific engineering to clinically relevant data sourcing, evolving antibody technologies advance oncology therapeutics.

Logical Biological, biospecimen and critical raw material leader, and Bcell Design, pioneers in transgenic monoclonal ...

Hospitalizations due to RSV cases in infants are reduced by up to 43% following the introduction of new maternal vaccines.

A groundbreaking universal snake antivenom, derived from rare human antibodies, offers hope against deadly bites worldwide.

Igyxos Biotherapeutics, a biotechnology company dedicated to developing innovative monoclonal antibodies for infertility ...

Researchers evaluated whether interferon-α nasal spray reduces the incidence of COVID-19 or other respiratory viral infections among adults with cancer.

A promising new treatment for Lyme disease, a condition transmitted through tick bites, is in development and aims to offer ...

AbCellera Biologics eyes long-term growth with a new facility, clinical trial progress, and a pivot to proprietary drug ...

Jade Biosciences (JBIO) unveiled JADE201, its investigational half-life extended, afucosylated monoclonal antibody targeting the B-cell activating ...

Regeneron’s monoclonal antibody trevogrumab, with or without the anti-activin A antibody garetosmab, appears to preserve lean ...

Scientists have discovered a potential new way to target Alzheimer's disease in the brain. The technique improved cognitive ...